Anzeige
❌
Mehr »
Sonntag, 15.11.2026 - Börsentäglich über 12.000 News
Pelican AI: +34,75% in Frankfurt! Ist das erst der Anfang einer großen Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire
688 Leser
Artikel bewerten:
(2)

Nasdaq Helsinki welcomes Aiforia Technologies to Nasdaq First North Growth Market Finland

Dec 10, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in Aiforia
Technologies Plc shares (short name: AIFORIA) commence today on Nasdaq First
North Growth Market Finland. The company belongs to Health care sector. Aiforia
Technologies is the 197th company to be admitted to trading on Nasdaq's Nordic
markets* in 2021, and it represents the 29th listing on Nasdaq Helsinki in
2021. 

Aiforia equips pathologists and scientists in preclinical and clinical labs
with powerful deep learning artificial intelligence software for translating
images into discoveries, decisions, and diagnoses. The cloud based Aiforia
products and services aim to escalate the efficiency and precision of medical
image analysis beyond current capabilities, across a variety of fields from
oncology to neuroscience and more. Our mission is to provide high-quality AI
solutions for image-based diagnostics, enabling personalized and better care
for patients. Find out more: www.aiforia.com 

Jukka Tapaninen, CEO of Aiforia Technologies, comments: "We are elated with the
interest and trust shown by investors in Aiforia. Pathologists are pivotal to
the healthcare system, investigating and diagnosing patient samples to guide
medical treatment. AI is able to bring precision and efficiency to evaluating
medical images, beyond that of current capabilities. The funds raised in the
IPO will support the planned implementation of Aiforia's growth strategy as
well as in taking new steps towards our mission to provide the highest quality
solutions for AI-assisted image analysis in pathology to enable personalised
and democratised care for patients. I warmly welcome our new shareholders!" 

 "We are proud to welcome Aiforia Technologies to Nasdaq First North Growth
Market," says Henrik Husman, President of Nasdaq Helsinki. "The artificial
intelligence software developed for medical needs by the company can help
patients get faster and better treatment, and it has an important role for
patients' well-being. Aiforia Technologies is a great addition to our Health
care sector." 

Aiforia Technologies has appointed UB Securities Oy as its Certified Adviser.

*Main markets and Nasdaq First North Growth Market at Nasdaq Copenhagen, Nasdaq
Helsinki, Nasdaq Iceland and Nasdaq Stockholm 


About Nasdaq First North Growth Market

Nasdaq First North Growth Market is a registered SME growth market, as defined
by the Directive on Markets in Financial Instruments (EU 2014/65). It does not
have the legal status as an EU-regulated market. Companies at Nasdaq First
North are subject to the rules of Nasdaq First North Growth Market and not the
legal requirements for admission to trading on a regulated market, such as the
Nasdaq Nordic Main Market. The risk in such an investment may be higher than on
the main market. 

The Premier segment within Nasdaq First North Growth Market is designed to
further assist companies in raising investor visibility and to prepare them for
a Main Market listing. The Premier segment targets companies that make a
conscious decision to comply with higher disclosure and accounting standards
than imposed under the Nasdaq First North Growth Market rules. 

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital
markets and other industries. Our diverse offering of data, analytics, software
and services enables clients to optimize and execute their business vision with
confidence. To learn more about the company, technology solutions and career
opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com. 

MEDIA CONTACT:
Maarit Bystedt
tel. +358 (0)9 6166 7274
maarit.bystedt@nasdaq.com
© 2021 GlobeNewswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.